
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, presented data at the Society for Maternal-Fetal Medicine (SMFM) Annual Pregnancy Meeting showing strong clinical performance of its Panorama®...

It's been one year since SelenBio, Inc.™?, a Texas-based biotechnology company, launched DenteShield™?, a dental product proven to inhibit bacteria colonization responsible for plaque, decay, white spot lesions and...

Greenphire, the global leader in financial software for clinical trials, and the Society for Clinical Research Sites (SCRS) today announced the findings of their new study, Financial Barriers to Site Sustainability,...

Indivior PLC (LON: INDV) today announced that data from its pivotal phase 3 clinical trial evaluating the efficacy, safety and tolerability of SUBLOCADETM (buprenorphine extended-release) injection for subcutaneous use...

Alkermes plc (Nasdaq: ALKS) and Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that the companies have entered into a research collaboration to evaluate ALKS 4230, Alkermes' investigational engineered...

Pfizer Inc. (NYSE: PFE) and Eli Lilly and Company (NYSE: LLY) today announced positive top-line results from a Phase 3 study evaluating tanezumab in patients with moderate-to-severe chronic low back pain (CLBP). In the...

According to a recent study by Columbia University, more than 40% of surviving spouses will struggle to adjust into their previous work and daily routines; and only 26% of widows return to their pre-loss level of life...

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has received an order from Radboud University Medical Center (Radboudumc) in the Netherlands for its IT solution for digital pathology. The...

Confirm BioSciences, maker of high-quality diagnostic testing and health & wellness solutions for both the corporate community and individual consumers, today announced its entry into retail distribution for its...

The Kroger Family of Pharmacies has worked with Houston-based MarkeTouch Media to apply an innovative and unique method of assisting patients through medication synchronization ("MedSync"). The solution leverages a central...

Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel small molecule pharmaceuticals with a primary focus in oncology, metabolic disease, and autoimmune...

AKL Research and Development (AKLRD) today announces its investigational medicine for osteoarthritis (OA) has been awarded a prestigious grant from Innovate UK, the leading government innovation agency.

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune and...

A NEW breast cancer drug shown to significantly reduce the risk of cancer recurrence is being made available to women in Singapore from today via a Special Access Program.

JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients...

The Association of Black Cardiologists, Inc. is a cosigner of the recently published 2018 ACC/AHA Guideline on Management of Blood Cholesterol, a document that was carefully crafted by the writing committee and experts in...

Therap's electronic health record and documentation system is the leading software globally and within the United States to providers supporting individuals with intellectual and developmental disabilities. Its...

ControlRad, LLC, a privately-held medical technology company, focused on dramatically reducing the amount of radiation exposure during fluoroscopically guided procedures, is pleased to announce that Chris Fair has joined...

Nektar Therapeutics (Nasdaq: NKTR) announced today a presentation of new clinical data for bempegaldesleukin1 (NKTR-214) in combination with nivolumab in patients with first-line (1L) advanced or metastatic urothelial...

Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive licensing rights for the global development and commercialization, for Vitrakvi®...

CStone Pharmaceuticals ("CStone") today announced that the National Medical Products Administration (NMPA) recently approved a Phase III clinical trial in China for its partnered drug candidate avapritinib as a third-line...

A positive prevention initiative designed to promote inclusion in middle schools was celebrated earlier this month by Big Sandy Junior High in Big Sandy, TX, Arp Junior High in Arp, TX and at Bowie Middle School in Odessa.

Glenmark Pharmaceuticals Ltd, a research-led integrated global pharmaceutical company, today announced that its Board of Directors has given an in-principle approval to spin off the innovation business into a new company...

The Janssen Pharmaceutical Companies of Johnson & Johnson will present today at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) early results from the ongoing Phase 2 GALAHAD study...

Lua Technologies, a subsidiary of Life Biosciences Inc, has been ranked the highest scoring post-acute secure messaging solution in the 2018 Secure Communication Decision Insights Report from KLAS Research. Lua received...

BTG plc (LSE: BTG), the global healthcare company, today announced the publication of data showing that cancer patients with presumed methotrexate toxicity treated with Voraxaze® (glucarpidase) had shorter hospital stays,...